Class information for:
Level 1: SELECTIVE ANDROGEN RECEPTOR MODULATOR//SARM//SARMS

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
23694 283 35.1 80%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
157 21931 BENIGN PROSTATIC HYPERPLASIA//PROSTATE CANCER//PROSTATE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SELECTIVE ANDROGEN RECEPTOR MODULATOR Author keyword 22 68% 7% 19
2 SARM Author keyword 17 52% 8% 23
3 SARMS Author keyword 15 68% 5% 13
4 AR ANTAGONIST Author keyword 5 60% 2% 6
5 PREVENT DOPING Address 5 14% 11% 31
6 PURE ANTAGONIST Author keyword 4 67% 1% 4
7 ENOBOSARM Author keyword 4 75% 1% 3
8 SELECTIVE ANDROGEN RECEPTOR MODULATORS Author keyword 4 44% 2% 7
9 DERMATOL BIOL Address 3 60% 1% 3
10 DOPING PREVENT Address 2 36% 2% 5

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 SELECTIVE ANDROGEN RECEPTOR MODULATOR 22 68% 7% 19 Search SELECTIVE+ANDROGEN+RECEPTOR+MODULATOR Search SELECTIVE+ANDROGEN+RECEPTOR+MODULATOR
2 SARM 17 52% 8% 23 Search SARM Search SARM
3 SARMS 15 68% 5% 13 Search SARMS Search SARMS
4 AR ANTAGONIST 5 60% 2% 6 Search AR+ANTAGONIST Search AR+ANTAGONIST
5 PURE ANTAGONIST 4 67% 1% 4 Search PURE+ANTAGONIST Search PURE+ANTAGONIST
6 ENOBOSARM 4 75% 1% 3 Search ENOBOSARM Search ENOBOSARM
7 SELECTIVE ANDROGEN RECEPTOR MODULATORS 4 44% 2% 7 Search SELECTIVE+ANDROGEN+RECEPTOR+MODULATORS Search SELECTIVE+ANDROGEN+RECEPTOR+MODULATORS
8 AR AGONIST 2 67% 1% 2 Search AR+AGONIST Search AR+AGONIST
9 GW1516 2 67% 1% 2 Search GW1516 Search GW1516
10 NONSTEROIDAL LIGANDS 2 67% 1% 2 Search NONSTEROIDAL+LIGANDS Search NONSTEROIDAL+LIGANDS

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SARMS 38 93% 5% 14
2 NONSTEROIDAL LIGANDS 13 61% 5% 14
3 STIMULATING HAIR GROWTH 11 100% 2% 6
4 BICALUTAMIDE ANALOGS 8 75% 2% 6
5 NONSTEROIDAL ANDROGEN 6 100% 1% 4
6 MODULATORS SARMS 5 60% 2% 6
7 ANDROGEN RECEPTOR MODULATORS 5 23% 6% 17
8 NONSTEROIDAL ANTIANDROGENS 4 29% 4% 11
9 S 4 ANDARINE 3 100% 1% 3
10 BICALUTAMIDE 3 12% 8% 23

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Nonsteroidal Selective Androgen Receptor Modulators (SARMs): Dissociating the Anabolic and Androgenic Activities of the Androgen Receptor for Therapeutic Benefit 2009 71 124 48%
Selective androgen receptor modulators for the prevention and treatment of muscle wasting associated with cancer 2013 11 40 53%
Deciphering the selective androgen receptor modulators paradigm 2013 11 110 35%
Recent advances in the development of selective androgen receptor modulators 2009 11 50 82%
Analytical approaches for the detection of emerging therapeutics and non-approved drugs in human doping controls 2014 5 135 16%
Mass spectrometry of selective androgen receptor modulators 2008 12 42 52%
Pharmacokinetics and pharmacodynamics of nonsteroidal androgen receptor ligands 2006 36 58 41%
AN OVERVIEW ON SElECTIVE ANDROGEN RECEPTOR MODUlATORS: FOCUS ON ENOBOSARM 2013 3 61 51%
Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs) 2007 78 55 24%
Selective androgen receptor modulators in drug discovery: Medicinal chemistry and therapeutic potential 2006 34 83 33%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 PREVENT DOPING 5 14% 11% 31
2 DERMATOL BIOL 3 60% 1.1% 3
3 DOPING PREVENT 2 36% 1.8% 5
4 BIOTHER EUT MED CHEM 1 50% 0.7% 2
5 NEW LEADS DISCOVERY 1 19% 2.1% 6
6 ZENTRUM PRAVENT DOPINGFOR 1 40% 0.7% 2
7 ONCOL MED CHEM 1 16% 1.4% 4
8 BIOSCINOVUM 1 50% 0.4% 1
9 DISCOVERY MED CHEM CHEM SCREENING SCI 0 33% 0.4% 1
10 UCLA OLYMP ANALYT 0 33% 0.4% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000210482 ANDROGEN RECEPTOR//ANDROGEN INSENSITIVITY SYNDROME//ANDROGEN INSENSITIVITY
2 0.0000129534 ANDROGEN DEPRIVATION THERAPY//INTERMITTENT ANDROGEN SUPPRESSION//BICALUTAMIDE
3 0.0000123152 SORF//5 METHOXYFLAVONE//7 MERCAPTO 4 METHYLCOUMARIN
4 0.0000096231 DOPING CONTROL//EPITESTOSTERONE//DOPING ANALYSIS
5 0.0000084468 HYPOGONADISM//LATE ONSET HYPOGONADISM//TESTOSTERONE REPLACEMENT THERAPY
6 0.0000078684 FLUOROESTRADIOL//F 18 FES PET//FES PET
7 0.0000075316 MALE CONTRACEPTION//VAS OCCLUSION//MALE HORMONAL CONTRACEPTION
8 0.0000068824 ANTIPROGESTIN//MIFEPRISTONE//ONAPRISTONE
9 0.0000068099 HERSHBERGER ASSAY//VINCLOZOLIN//NIPPLE RETENTION
10 0.0000062695 ATLAS PROJECT//AUXIN A//AUXIN B